Search - tctmd.com

Displaying 301 - 320 of 423

Sort: Relevancy | Date

Presentation TCT 2014

Mechanisms, Predictors, and Unusual Causes of In-Stent Restenosis

Presenter: Soo-Jin Kang, Akiko Maehara, Gary S. Mintz, Lisette Okkels Jensen

September 15, 2014

Presentation TCT 2014

DCB Use in the Real World I: In-Stent Restenosis Insights From the FAIR Trial

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri

September 15, 2014

Presentation TCT 2014

TCT 270: Comparison Among a Drug-Eluting Balloon, Drug-Eluting Stent, and Plain Balloon Angioplasty for Treatment of In-Stent Restenosis: A Network Meta-analysis of 11 Randomized Controlled Trials

Presenter: John A. Bittl, Tullio Palmerini, Joo Myung Lee, MD

September 15, 2014

Presentation TCT 2014

Advanced Treatment Options for Recurrent DES Restenosis: From Drugs to Brachytherapy

Presenter: Robert S. Schwartz, Ron Waksman, Jorge F. Saucedo, Paul S. Teirstein

September 14, 2014

Presentation TCT 2014

Treatment Options for BMS and DES ISR: What Works Best?

Presenter: Robert S. Schwartz, Ron Waksman, Jorge F. Saucedo, Fernando Alfonso

September 14, 2014

Presentation TCT 2014

Use of OCT to Evaluate Stent Failures (Thrombosis and Restenosis)

Presenter: Robert S. Schwartz, Ron Waksman, Jorge F. Saucedo, Evelyn S. Regar

September 14, 2014

Presentation TCT 2014

Use of IVUS to Evaluate Stent Failures (Thrombosis and Restenosis)

Presenter: Robert S. Schwartz, Ron Waksman, Jorge F. Saucedo, Gary S. Mintz

September 14, 2014

Presentation TCT 2014

RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents

Presenter: Gregg W. Stone, Pieter C. Smits, Fernando Alfonso

September 14, 2014

Presentation TCT 2014

Excimer Laser for Femoropopliteal In-Stent Restenosis: Light at the End of the Tunnel?

Presenter: John R. Laird Jr, Daniel J. McCormick, Dmitriy N. Feldman, Carlos I. Mena-Hurtado

September 13, 2014

Presentation TCT 2014

TCT 267: Lower Mortality of Paclitaxel-Coated Balloon Compared with Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis: Two-Year Follow-up of the PEPCAD China ISR Trial

Presenter: Run-Lin Gao, Jochen Wöhrle, Bruno Scheller, Yelin Zhao

September 13, 2014

Presentation TCT 2014

DCB in BMS vs DES ISR: Insights from the RIBS Trials

Presenter: Run-Lin Gao, Jochen Wöhrle, Bruno Scheller, Fernando Alfonso

September 13, 2014

Presentation TCT 2014

Approach to In-Stent Restenosis in 2014: DCB or DES?

Presenter: Run-Lin Gao, Jochen Wöhrle, Bruno Scheller, Robert A. Byrne

September 13, 2014

Presentation TCT 2014

Restenosis and Stent Thrombosis

Presenter: George D. Dangas, Kevin J. Croce

September 13, 2014

Presentation TCT 2014

Consensus and Take-home Messages

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton

September 13, 2014

Presentation TCT 2014

How Did I Treat This Case?

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton, Alejandro D Fernandez

September 13, 2014

Presentation TCT 2014

How Would I Treat This Case?

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton, Eric Van Belle

September 13, 2014

Presentation TCT 2014

Case #2: A Challenging Restenosis Lesion

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton, Alejandro D Fernandez

September 13, 2014

Presentation TCT 2014

Consensus and Take-home Messages

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton

September 13, 2014

Presentation TCT 2014

How Did I Treat This Case?

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton, Jacques Berland

September 13, 2014

Presentation TCT 2014

How Would I Treat This Case?

Presenter: Alejandro Cherro, Carlo Di Mario, Hervé Le Breton, Miguel A Larribau

September 13, 2014

Advertisement

Mechanisms, Predictors, and Unusual Causes of In-Stent Restenosis

DCB Use in the Real World I: In-Stent Restenosis Insights From the FAIR Trial

TCT 270: Comparison Among a Drug-Eluting Balloon, Drug-Eluting Stent, and Plain Balloon Angioplasty for Treatment of In-Stent Restenosis: A Network Meta-analysis of 11 Randomized Controlled Trials

Advanced Treatment Options for Recurrent DES Restenosis: From Drugs to Brachytherapy

Treatment Options for BMS and DES ISR: What Works Best?

Use of OCT to Evaluate Stent Failures (Thrombosis and Restenosis)

Use of IVUS to Evaluate Stent Failures (Thrombosis and Restenosis)

RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents

Excimer Laser for Femoropopliteal In-Stent Restenosis: Light at the End of the Tunnel?

TCT 267: Lower Mortality of Paclitaxel-Coated Balloon Compared with Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis: Two-Year Follow-up of the PEPCAD China ISR Trial

DCB in BMS vs DES ISR: Insights from the RIBS Trials

Approach to In-Stent Restenosis in 2014: DCB or DES?

Restenosis and Stent Thrombosis

Consensus and Take-home Messages

How Did I Treat This Case?

How Would I Treat This Case?

Case #2: A Challenging Restenosis Lesion

Consensus and Take-home Messages

How Did I Treat This Case?

How Would I Treat This Case?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content